Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment

Author： Kahan Barry

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.5, 2011-09, pp. : 727-749

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the mammalian target of rapamycin

By Dancey Janet E

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 313-328

Informa Healthcare

Access to resources Recommend Favorite

Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer

By Nelson Valerie Altman Jessica K Platanias Leonidas C

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

Current and future directions in mammalian target of rapamycin inhibitors development

By Fasolo Angelica Sessa Cristiana

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 381-394

Informa Healthcare

Access to resources Recommend Favorite

New inhibitors of the mammalian target of rapamycin signaling pathway for cancer

By Albert Sébastien Serova Maria Dreyer Chantal Sablin Marie-Paule Faivre Sandrine Raymond Eric

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 919-930

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside

By Vincenzi Bruno Napolitano Andrea D'Onofrio Loretta Frezza Anna Maria Silletta Marianna Venditti Olga Santini Daniele Tonini Giuseppe

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1685-1705

Informa Healthcare

Access to resources Recommend Favorite